Create Free Account

By creating account you will get access to hot stocks & personalised emails

Oceania Healthcare Ltd

Healthcare AU OCA

0.66AUD
0.005(0.76%)

Last update at 2024-11-11T23:07:00Z

Day Range

0.660.66
LowHigh

52 Week Range

0.470.80
LowHigh

Fundamentals

  • Previous Close 0.66
  • Market Cap505.06M
  • Volume4
  • P/E Ratio16.25
  • Dividend Yield-%
  • EBITDA6.78M
  • Revenue TTM265.46M
  • Revenue Per Share TTM0.37
  • Gross Profit TTM 85.03M
  • Diluted EPS TTM0.04

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Type yearly yearly yearly yearly yearly
Date 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Income before tax 12.00M 56.25M 75.14M 31.80M 75.88M
Minority interest - - - - -
Net income 15.45M 61.13M 85.53M 45.37M 76.97M
Selling general administrative 164.64M 158.94M 115.69M 127.33M 122.36M
Selling and marketing expenses - - - - -
Gross profit 247.18M 231.14M - 186.98M 180.05M
Reconciled depreciation 17.92M 18.62M - 14.49M 9.54M
Ebit 35.44M 70.39M -4.01280M 49.98M 77.58M
Ebitda 53.36M 89.01M - 59.52M 86.42M
Depreciation and amortization 17.92M 18.62M - 9.54M 8.84M
Non operating income net other - - - - -
Operating income 35.44M 70.39M 3.67M -20.29800M 2.38M
Other operating expenses 247.62M 236.72M 56.91M 213.94M 184.60M
Interest expense 13.87M 8.85M 0.00000M 3.00M 2.94M
Tax provision -3.44800M -4.87900M -10.39600M -14.66600M -13.57600M
Interest income 1.76M 0.08M 73.68M 28.92M 43.33M
Net interest income -12.55600M -9.30300M - -5.10600M -2.85200M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -3.44800M -4.87900M -12.47520M -13.57600M -1.09600M
Total revenue 247.18M 231.14M 175.42M 186.98M 180.05M
Total operating expenses 247.62M 236.72M - 184.60M 151.43M
Cost of revenue - - - - 123.75M
Total other income expense net -23.43900M -14.14100M - 32.91M 50.03M
Discontinued operations - - - - -
Net income from continuing ops 15.45M 61.13M - -13.64200M 45.37M
Net income applicable to common shares 15.45M 61.13M 102.82M -13.64200M 45.37M
Preferred stock and other adjustments - - - - -
Breakdown 2024-05-31 2023-05-31 2022-05-31 2021-05-31 2020-05-31
Type yearly yearly yearly yearly yearly
Date 2024-05-31 2023-05-31 2022-05-31 2021-05-31 2020-05-31
Total assets 2782.35M 2544.94M 2197.69M 1883.73M 1548.70M
Intangible assets 2.78M 3.55M 3.67M 5.23M 4.26M
Earning assets - - - - -
Other current assets 44.26M 101.65M 6.61M 2.00M 1.40M
Total liab 1755.89M 1582.68M 1248.85M 1048.53M 953.48M
Total stockholder equity 1026.46M 962.26M 948.84M 835.20M 595.21M
Deferred long term liab - - - - -
Other current liab 1004.77M 969.17M 814.70M 623.78M 535.37M
Common stock 715.96M 713.37M 705.29M 675.62M 588.39M
Capital stock 715.96M 713.37M 705.29M - 588.39M
Retained earnings -34.26400M -68.49600M -54.73500M -86.98300M -155.90700M
Other liab - 66.87M 65.07M 60.12M 51.00M
Good will 2.88M 3.17M 4.93M 5.34M 6.57M
Other assets - 1597.72M 1378.55M 1099.80M 947.80M
Cash 7.49M 7.44M 9.74M 79.91M 17.62M
Cash and equivalents - - - - -
Total current liabilities 1104.17M 1024.29M 858.81M 647.22M 615.03M
Current deferred revenue 47.34M 45.33M 42.07M - 34.34M
Net debt 644.24M 550.95M 380.29M - 320.83M
Short term debt 37.08M - - - 39.46M
Short long term debt - - - - -
Short long term debt total 651.72M 558.39M 390.03M 327.29M 338.45M
Other stockholder equity - 317.38M 298.29M 244.98M 162.73M
Property plant equipment - 716.46M 727.73M 645.99M 530.81M
Total current assets 179.64M 224.05M 82.80M 127.90M 59.25M
Long term investments 1815.39M 1597.72M 1378.55M - 947.80M
Net tangible assets - 955.54M 940.24M 825.16M 584.38M
Short term investments - - - - 66.13M
Net receivables 120.03M 106.47M 66.45M 43.10M 40.23M
Long term debt 640.52M 553.59M 380.14M 327.29M 325.45M
Inventory 0.00000M - - - -0.02700M
Accounts payable 14.97M 9.79M 2.04M 9.30M 5.86M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 344.76M 317.38M 298.29M - 162.73M
Additional paid in capital - - - - -
Common stock total equity - - - - 588.39M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 1818.42M - - - 40.82M
Deferred long term asset charges - - - - -
Non current assets total 2602.71M 2320.89M 2114.89M - 1489.44M
Capital lease obligations 11.21M 4.80M 9.89M - 13.00M
Long term debt total - - - 327.29M 325.45M
Breakdown 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Type yearly yearly yearly yearly yearly
Date 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Investments -219.60100M -218.82000M - -135.98300M -153.77400M
Change to liabilities 11.33M -1.75700M 7.29M 0.09M 4.69M
Total cashflows from investing activities -219.60100M -218.82000M -122.62800M -135.98300M -153.77400M
Net borrowings 171.07M 44.22M -1.65600M 54.31M 96.68M
Total cash from financing activities 147.09M 43.13M 82.22M 31.48M 56.59M
Change to operating activities - - - - -
Net income 15.45M 61.13M 102.82M -13.64200M 45.37M
Change in cash -2.30600M -70.16100M 74.74M -5.13800M 7.43M
Begin period cash flow 9.74M 79.91M 17.62M 22.76M 10.86M
End period cash flow 7.44M 9.74M 79.91M 17.62M 18.29M
Total cash from operating activities 15.45M 18.62M 115.14M 99.37M 89.32M
Issuance of capital stock - 20.00M - - 1.30M
Depreciation 17.27M 18.62M 16.03M 14.49M 9.54M
Other cashflows from investing activities - - -66.00500M -95.51600M -80.87900M
Dividends paid -21.80600M -19.41800M 7.56M -22.22700M -12.73200M
Change to inventory - - - - -
Change to account receivables 5.64M 13.11M -2.72520M -2.59500M 0.29M
Sale purchase of stock - - - 1.30M 1.30M
Other cashflows from financing activities 223.19M 158.02M -4.56000M 166.33M 117.20M
Change to netincome 19.86M 14.43M -8.47920M 101.02M 29.42M
Capital expenditures 55.16M 56.29M 43.42M 40.43M 33.39M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital - - -56.24800M -59.42400M -44.91200M
Stock based compensation - - - - -
Other non cash items -15.44800M -79.74900M - -0.85000M -54.91500M
Free cash flow -39.71200M -37.66900M - -40.43300M -33.38900M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
OCA
Oceania Healthcare Ltd		 0.005 0.76% 0.66 16.25 - 1.90 0.51 4.53 18.97
RHCPA
Ramsay Health Care Ltd Pref		 -0.13 0.12% 105.00 64.82 - 0.85 - - -
RHC
Ramsay Health Care Ltd		 -0.79 2.06% 37.63 33.39 28.57 0.53 1.85 1.17 10.70
SNZ
Summerset Group Holdings Ltd		 -0.08 0.69% 11.44 7.24 - 9.11 1.10 24.28 15.54
REG
Regis Healthcare Ltd		 -0.27 4.06% 6.38 - 24.39 1.90 259.34 1.88 9.98

Reports Covered

Stock Research & News

View All

Profile

Oceania Healthcare Limited, together with its subsidiaries, owns and operates various care centers and retirement villages in New Zealand. The company operates through Care Operations, Village Operations, and Other segments. It also provides rest home, hospital, and dementia. In addition, the company offers independent living and rental properties for caring suites. Further, it provides accommodation, care, and related services to aged care residents; and support services, including administration, marketing, and operations. The company was formerly known as Retirement Care (NZ) Limited and changed its name to Oceania Healthcare Limited in September 2014. Oceania Healthcare Limited was incorporated in 2005 and is based in Auckland, New Zealand.

Oceania Healthcare Ltd

HSBC Tower, Auckland, New Zealand, 1010

Key Executives

Name Title Year Born
Mr. Brent Pattison BBS, C.A. Chief Exec. Officer NA
Ms. Kathryn Waugh Chief Financial Officer NA
Anita Hawthorne B.Com., C.A. Group Gen. Mang. of Sales & Services NA
Dr. Frances Hughes Gen. Mang. - Nursing & Clinical Strategy NA
Eli Parkin Head of Devel. NA
Mr. Brent Pattison BBS, C.A. Chief Executive Officer NA
Anita Hawthorne B.Com., C.A. Group General Manager of Sales & Services NA
Eli Parkin Head of Development NA
Mr. Brent Pattison BBS, C.A. Chief Executive Officer NA
Anita Hawthorne B.Com., C.A. Group General Manager of Sales & Services NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.